|
GINMU >
Browsing by Author Akahane, Takemi
Showing results 10 to 19 of 19
Issue Date | Title | Author(s) |
Oct-2023 | Glucagon-like peptide-1 receptor agonist, semaglutide attenuates chronic liver disease-induced skeletal muscle atrophy in diabetic mice | Iwai, Satoshi; Kaji, Kosuke; Nishimura, Norihisa; Kubo, Takahiro; Tomooka, Fumimasa; Shibamoto, Akihiko; Suzuki, Junya; Tsuji, Yuki; Fujinaga, Yukihisa; Kitagawa, Koh; Namisaki, Tadashi; Akahane, Takemi; Yoshiji, Hitoshi |
Apr-2021 | Lenvatinib prevents liver fibrosis by inhibiting hepatic stellate cell activation and sinusoidal capillarization in experimental liver fibrosis. | Ogawa, Hiroyuki; Kaji, Kosuke; Nishimura, Norihisa; Takagi, Hirotetsu; Ishida, Koji; Takaya, Hiroaki; Kawaratani, Hideto; Moriya, Kei; Namisaki, Tadashi; Akahane, Takemi; Yoshiji, Hitoshi |
Oct-2022 | Rifaximin and lubiprostone mitigate liver fibrosis development by repairing gut barrier function in diet–induced rat steatohepatitis | Enomoto, Masahide; Kaji, Kosuke; Nishimura, Norihisa; Fujimoto, Yuki; Murata, Koji; Takeda, Soichi; Tsuji, Yuki; Fujinaga, Yukihisa; Tanaka, Hiroaki; Kawaratani, Hideto; Namisaki, Tadashi; Akahane, Takemi; Yoshiji, Hitoshi |
Aug-2022 | Rifaximin enhances the L‑carnitine‑mediated preventive effects on skeletal muscle atrophy in cirrhotic rats by modulating the gut‑liver‑muscle axis | Murata, Koji; Kaji, Kosuke; Nishimura, Norihisa; Enomoto, Masahide; Fujimoto, Yuki; Takeda, Soichi; Tsuji, Yuki; Fujinaga, Yukihisa; Takaya, Hiroaki; Kawaratani, Hideto; Namisaki, Tadashi; Akahane, Takemi; Yoshiji, Hitoshi |
Mar-2021 | Sulforaphane ameliorates ethanol plus carbon tetrachloride-induced liver fibrosis in mice through the Nrf2-mediated antioxidant response and acetaldehyde metabolization with inhibition of the LPS/TLR4 signaling pathway. | Ishida, Koji; Kaji, Kosuke; Sato, Shinya; Ogawa, Hiroyuki; Takagi, Hirotetsu; Takaya, Hiroaki; Kawaratani, Hideto; Moriya, Kei; Namisaki, Tadashi; Akahane, Takemi; Yoshiji, Hitoshi |
Dec-2018 | Sulforaphane Inhibits Liver Cancer Cell Growth and Angiogenesis. | Sato, Shinya; Moriya, Kei; Furukawa, Masanori; Saikawa, Soichiro; Namisaki, Tadashi; Kitade, Mitsuteru; Kawaratani, Hideto; Kaji, Kosuke; Takaya, Hiroaki; Shimozato, Naotaka; Sawada, Yasuhiko; Seki, Kenichiro; Kitagawa, Kou; Akahane, Takemi; Mitoro, Akira; Okura, Yasushi; Yoshiji, Hitoshi; Yamao, Junichi |
Feb-2023 | Sulforaphane Potentiates Gemcitabine-Mediated Anti-Cancer Effects against Intrahepatic Cholangiocarcinoma by Inhibiting HDAC Activity | Tomooka, Fumimasa; Kaji, Kosuke; Nishimura, Norihisa; Kubo, Takahiro; Iwai, Satoshi; Shibamoto, Akihiko; Suzuki, Junya; Kitagawa, Koh; Namisaki, Tadashi; Akahane, Takemi; Mitoro, Akira; Yoshiji, Hitoshi |
26-Sep-2019 | TGR5 Activation Modulates an Inhibitory Effect on Liver Fibrosis Development Mediated by Anagliptin in Diabetic Rats. | Kaya, Daisuke; Kaji, Kosuke; Tsuji, Yuki; Yamashita, Satoko; Kitagawa, Koh; Ozutsumi, Takahiro; Fujinaga, Yukihisa; Takaya, Hiroaki; Kawaratani, Hideto; Moriya, Kei; Namisaki, Tadashi; Akahane, Takemi; Yoshiji, Hitoshi |
5-Mar-2021 | The Angiotensin II Receptor Blocker Losartan Sensitizes Human Liver Cancer Cells to Lenvatinib-Mediated Cytostatic and Angiostatic Effects. | Takagi, Hirotetsu; Kaji, Kosuke; Nishimura, Norihisa; Ishida, Koji; Ogawa, Hiroyuki; Takaya, Hiroaki; Kawaratani, Hideto; Moriya, Kei; Namisaki, Tadashi; Akahane, Takemi; Mitoro, Akira; Yoshiji, Hitoshi |
Dec-2023 | Vitamin D deficiency exacerbates alcohol-related liver injury via gut barrier disruption and hepatic overload of endotoxin | Shibamoto, Akihiko; Kaji, Kosuke; Nishimura, Norihisa; Kubo, Takahiro; Iwai, Satoshi; Tomooka, Fumimasa; Suzuki, Junya; Tsuji, Yuki; Fujinaga, Yukihisa; Kawaratani, Hideto; Namisaki, Tadashi; Akahane, Takemi; Yoshiji, Hitoshi |
Showing results 10 to 19 of 19
|